US EditionSingle dose of CAR-astrocyte therapy halves amyloid levels in mice brains
A single injection of CAR-engineered astrocytes halved amyloid plaques in Alzheimer's mice and prevented plaque development when given early, researchers reported.
5 Articles
5 Articles
Improved brain cells eliminate dementia-related proteins
Early CAR-Astrocyte Therapy Prevents Plaque Formation in Alzheimer's Mouse Model
Researchers at Washington University School of Medicine in St. Louis have developed genetically altered astrocytes that express chimeric antigen receptors (CARs) as a promising immunotherapy system capable of clearing accumulations of amyloid-β (Aβ)—a hallmark pathological feature of Alzheimer’s disease (AD)—in the brains of mice. Recently approved anti-Aβ antibody therapies have shown moderate success in slowing AD progression. However, these t…
A team of scientists has designed a new immunotherapy that causes brain cells called astrocytes to remove amyloid plaques that cause alzhéimer. The entry Tested cell immunotherapy to treat alzhéimer successfully in mice was first published in La Voz de Michoacán.
Enhanced Brain Cells Clear Away Dementia-Related Proteins
Newswise — The new generation of Alzheimer’s disease drugs — the first proven to change the course of the disease — typically extend independent living for patients by 10 months. Called monoclonal antibodies, they reduce the accumulations of a harmful protein, amyloid, in the brain and require high-dose, once- or twice-monthly infusions of the medication. Now, to reduce the frequency of treatment and potentially improve the efficacy of an anti-a…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
